4//SEC Filing
Downs Christopher 4
Accession 0001683168-23-002095
CIK 0001729427other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 7:28 PM ET
Size
6.1 KB
Accession
0001683168-23-002095
Insider Transaction Report
Form 4
Downs Christopher
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2023-03-29+6,067→ 28,768 total→ Common stock (6,067 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one shares of Issuer common stock.
- [F2]The restricted stock units set forth in this table vest as follows, subject to the grantee's continued service to the Company on each vesting date, (i) 50% of the grant will vest in four equal annual installments over 4 years; (ii) 25% of the grant will vest if within 24 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $6.00 (subject to pro rata adjustment for stock splits or similar events); and (iii) 25% of the grant will vest if within 36 months from issuance the average the closing price of the Issuer common stock over a ten trading day period exceeds $24.00 (subject to pro rata adjustment for stock splits or similar events).
- [F3]Issued in connection with the reporting person's employment with the Company.
Documents
Issuer
CNS Pharmaceuticals, Inc.
CIK 0001729427
Entity typeother
Related Parties
1- filerCIK 0001705978
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 7:28 PM ET
- Size
- 6.1 KB